Sutro Biopharma (STRO)
(Delayed Data from NSDQ)
$0.90 USD
+0.05 (5.88%)
Updated Sep 18, 2025 04:00 PM ET
After-Market: $0.90 0.00 (-0.31%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth B Momentum C VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
STRO 0.90 +0.05(5.88%)
Will STRO be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for STRO based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for STRO
Sutro Biopharma, Inc. (STRO) Reports Q2 Loss, Beats Revenue Estimates
Cytokinetics (CYTK) Reports Q2 Loss, Tops Revenue Estimates
STRO: What are Zacks experts saying now?
Zacks Private Portfolio Services
Teladoc (TDOC) Moves 14.4% Higher: Will This Strength Last?
Exelixis (EXEL) Surges 7.4%: Is This an Indication of Further Gains?
Strength Seen in Nektar (NKTR): Can Its 12.1% Jump Turn into More Strength?
Other News for STRO
STRO Fell Below 50 Day Moving Average on September 18
H.C. Wainwright Sticks to Their Hold Rating for Sutro Biopharma (STRO)
Is STRO gathering momentum? NR7 shows up after climbing 0.38%
Technical picture remains unchanged for STRO after it rises 1.29% on September 15
STRO Fell Below 20 Day Moving Average on September 12